No 03 2018

Elicera Therapeutics' drug candidate ELC-100 has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic neuroendocrine tumors.

Researchers at the University of Gothenburg, in collaboration with colleagues in China, have discovered an antibody-like molecule that can protect mice from various influenza viruses.

AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority Review in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) who have received prior systemic therapies, including an EGFR-directed therapy.

According to Professor Matthias Christandl, Leader of the Quantum for Life Centre in Copenhagen, the potential of quantum computing within life sciences is enormous and in order to take the lead, investments in both quantum hardware and software is essential.

Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024.

Enzymatica has announced that Anna Söderlund has joined as the new Senior Director Marketing & Sales.

Alice Long, a leading expert in translational immunology and diabetes research, has joined Diamyd Medical’s Scientific Advisory Board (SAB).